Ardent Health, Inc.
ARDT
$12.53
-$0.16-1.26%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 1.65B | 1.50B | 1.61B | 1.45B | 1.47B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 1.65B | 1.50B | 1.61B | 1.45B | 1.47B |
Cost of Revenue | 671.70M | 657.65M | 653.97M | 635.22M | 624.06M |
Gross Profit | 973.58M | 839.58M | 952.32M | 814.59M | 846.86M |
SG&A Expenses | 633.30M | 605.52M | 615.53M | 589.74M | 593.25M |
Depreciation & Amortization | 39.31M | 36.20M | 37.85M | 36.77M | 36.31M |
Other Operating Expenses | 163.70M | 130.77M | 141.37M | 117.70M | 115.32M |
Total Operating Expenses | 1.51B | 1.43B | 1.45B | 1.38B | 1.37B |
Operating Income | 137.28M | 67.09M | 157.57M | 70.38M | 101.99M |
Income Before Tax | 121.99M | 74.20M | 167.25M | 57.07M | 82.18M |
Income Tax Expenses | 26.29M | 15.23M | 26.36M | 11.06M | 15.22M |
Earnings from Continuing Operations | 95.70M | 58.97M | 140.89M | 46.01M | 66.96M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -22.75M | -17.58M | -26.69M | -19.68M | -24.19M |
Net Income | 72.95M | 41.38M | 114.20M | 26.32M | 42.77M |
EBIT | 137.28M | 67.09M | 157.57M | 70.38M | 101.99M |
EBITDA | 176.59M | 103.29M | 195.43M | 107.15M | 138.30M |
EPS Basic | 0.52 | 0.30 | 0.82 | 0.19 | 0.34 |
Normalized Basic EPS | 0.38 | 0.11 | 0.46 | 0.12 | 0.22 |
EPS Diluted | 0.52 | 0.29 | 0.81 | 0.19 | 0.34 |
Normalized Diluted EPS | 0.38 | 0.11 | 0.46 | 0.12 | 0.22 |
Average Basic Shares Outstanding | 140.37M | 140.06M | 140.04M | 137.11M | 126.12M |
Average Diluted Shares Outstanding | 141.52M | 140.70M | 140.83M | 137.54M | 126.12M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |